title: Kinetics of Diol and Hydroxybenzo[a]pyrene Metabolites in Relation to DNA Adduct Formation and Gene Expression in Rats.
abstract: Benzo[a]pyrene (BaP) is a human carcinogen, but there are no validated biomarkers of exposure and the relationship of carcinogenesis with early biological alterations is not fully documented. This study aimed at better documenting the toxicokinetics of diolBaP and hydroxyBaP metabolites as potential biomarkers of exposure to BaP in relation to DNA adduct formation and gene expression. Rats were intravenously (iv) injected with 40 μmol/kg BaP. BaP and several metabolites were measured in blood, tissues, and excreta collected at frequent intervals over 72 h posttreatment. BaP diol epoxide (BaPDE)-DNA adduct formation and gene expression were assessed in lungs. 3-HydroxyBaP (3-OHBaP) and 4,5-diolBaP were the most abundant measured metabolites, and differences in time courses were apparent between the two metabolites. Over the 0-72 h period, mean proportions of BaP dose recovered in urine as 3-OHBaP and 4,5-diolBaP (±SD) were 0.017 ± 0.003% and 0.1 ± 0.03%. Corresponding values in feces were 1.5 ± 0.5% and 0.42 ± 0.052%. BaPDE-DNA adducts were significantly increased in lungs and a correlation was observed with urinary 3-OHBaP and 4,5-diolBaP. Analysis of gene expression showed a modulation of expression of metabolic genes (Cyp1a1, Cyp1b1, Nqo1, Ahr) and oxidative stress and repair genes (Nrf2, Rad51). However, BaPDE adducts formation did not exhibit any significant correlation with expression of genes, except a negative correlation with Rad51 expression. Similarly, there was no significant correlation between urinary excretion of OHBaP and diolBaP and expression of genes, except for urinary 7-OHBaP excretion, which was negatively correlated with Rad51 expression. Results indicate that concomitant measurements of diolBaP and OHBaP may serve to better assess the extent of exposure as compared to single metabolite measurements, given kinetic differences between metabolites. Further, although some urinary metabolites were correlated with BaPDE adducts, links with gene expression need to be further investigated.
authors.affiliation: a Department of Environmental and Occupational Health , Chair in Toxicological Risk Assessment and Management and the Research Institute of Public Health of the University of Montreal (IRSPUM), University of Montreal , Montreal , Quebec , Canada.
authors.forename: Marjory
authors.initials: M
authors.lastname: Moreau
authors.forename: Pierre
authors.initials: P
authors.lastname: Ayotte
authors.forename: Michèle
authors.initials: M
authors.lastname: Bouchard
mesh_terms: D000818:Animals; D001564:Benzo(a)pyrene / Q000032:analysis / Q000493:pharmacokinetics* / Q000633:toxicity*; D015415:Biomarkers / Q000032:analysis; D001711:Biotransformation; D018736:DNA Adducts / Q000032:analysis / Q000187:drug effects*; D005243:Feces / Q000737:chemistry; D015870:Gene Expression / Q000187:drug effects*; D006900:Hydroxylation; D008297:Male; D009153:Mutagens / Q000633:toxicity*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D015415:Biomarkers; D018736:DNA Adducts; D009153:Mutagens; C056612:benzo(a)pyrene-DNA adduct; D001564:Benzo(a)pyrene